|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06887 SUNSHINE PHARMA
Nominal 
() | 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 4,018,905 | -37.063% | 6,385,616 | 3,813,566 |
| Cost of Sales | (960,274) | -26.616% | (1,308,568) | (891,377) |
| Gross Profit | 3,058,631 | -39.756% | 5,077,048 | 2,922,189 |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 293 | -- | (29) | 0 | |
| Profit / (Loss) before Taxation | 141,054 | -89.819% | 1,385,462 | (1,479,823) | |
| Taxation | (116,251) | -68.715% | (371,584) | 63,908 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | |
| Non-controlling Interests | (232,237) | -71.984% | (828,954) | 206,710 | |
| Others | -- | -- | -- | 124,582 | |
| Profit / (Loss) Attributable to Shareholders | (207,434) | -- | 184,924 | (1,084,623) | |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 177,504 | -39.148% | 291,698 | 634,056 |
| Depreciation & Amortisation | 418,044 | -0.452% | 419,941 | 398,674 |
| Directors' Emoluments | 92,268 | 92.840% | 47,847 | 3,563 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | |
| EPS (cts) | -47.000 | -- | 44.000 | -329.000 |
| DPS (cts) | -- | -- | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- |
| Cash flow per share ($) | 1.135 | -- | 3.145 | 3.521 |
| NBV per share ($) | 0.597 | -- | 0.569 | (6.397) |
| Remarks: | Real time quote last updated: 18/07/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -207,434 |
| %Change | -- |
| EPS / (LPS) | RMB -0.470 |
| NBV Per Share (¥) | RMB 0.597 |